Showing 11,241 - 11,260 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((latent decrease) OR (largest decrease)) ))', query time: 1.60s Refine Results
  1. 11241

    Dendritic Silica Nanospheres with Au–Pt Nanoparticles as Nanozymes for Label-Free Colorimetric Hg<sup>2+</sup> Detection by Jiaojiao Zhou (432827)

    Published 2022
    “…The detection limit was 8.58 pM with a linear range from 0.1 nM to 10 μM. Selectivity toward Hg<sup>2+</sup> has also been demonstrated in aqueous solutions in the presence of other metal ions. …”
  2. 11242
  3. 11243
  4. 11244
  5. 11245
  6. 11246

    High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation by Michiel G. H. Betjes (8407413)

    Published 2020
    “…</p><p>Methods</p><p>Recipients of a kidney transplant in the period 2007–2013 were (N = 365) were included. …”
  7. 11247
  8. 11248
  9. 11249
  10. 11250
  11. 11251

    Erratum: A Synergistic Association of ACE I/D and eNOS G894T Gene Variants with the Progression of Immunoglobulin A Nephropathy – A Pilot Study by Rodríguez-Pérez J.C. (4271464)

    Published 2017
    “…The primary outcome was ‘kidney survival’ defined as a 30% decrease of baseline creatinine clearance; annualized decrease of glomerular filtration rate was also calculated. …”
  12. 11252

    Group 2 biomechanical testing of fractured limb callus at day 28 after fracture–Mechanical assessment of samples showed a higher twist angle and strain energy in the probiotic treatment post-fracture group with a decrease in torsional stiffness *P<0.05. by Yufa Wang (317537)

    Published 2023
    “…<p>Group 2 biomechanical testing of fractured limb callus at day 28 after fracture–Mechanical assessment of samples showed a higher twist angle and strain energy in the probiotic treatment post-fracture group with a decrease in torsional stiffness *P<0.05.…”
  13. 11253
  14. 11254
  15. 11255
  16. 11256

    Estimated marginal means for changes in outcome parameters A, B, C, D. by Benjamin Udoka Nwosu (476930)

    Published 2015
    “…<p>A. Hemoglobin A1c: Over the course of our 9 months of observation, the between-treatment differences in HbA1c of 0.4% (9.85% [8.82 to 10.88] for placebo versus 9.46% [8.47 to 10.46] for metformin) was not significant (p = 0.903). …”
  17. 11257
  18. 11258
  19. 11259
  20. 11260